Results 51 to 60 of about 4,186 (197)

The Relevance of Blepharoptosis in Diagnostic Suspicion of Myopathies

, 2021
Blepharoptosis (ptosis) is classified, based on etiology, into mechanical, cerebral, neurogenic, neuromuscular, myogenic, and due to miscellaneous causes. Primary myopathic diseases are rare causes of blepharoptosis and many patients with myogenic ptosis
Papadimas, George K., Papadopoulos, Constantinos   +1 more
core  

Journey of frontalis muscle advancement in severe blepharoptosis: Review of the techniques, modifications, and outcomes

Indian Journal of Ophthalmology
We aimed to review the degree of standardization of frontalis muscle (FM)–orbicularis muscle advancement techniques in the management of severe congenital blepharoptosis and also study the evidence which supports the procedure correcting blepharoptosis ...
Kasturi Bhattacharjee, Komal Sawarkar, Deepak Soni, Gargi Wavikar   +3 more
doaj   +1 more source

Identifying Red Flags in Myasthenia Gravis Diagnosis, Reassessment, and Myasthenic Crisis: An Italian Delphi‐Based Position Paper

Acta Neurologica Scandinavica, Volume 2026, Issue 1, 2026.
Background and Purpose Myasthenia gravis (MG) is a complex autoimmune disorder affecting neuromuscular transmission, often leading to diagnostic and therapeutic challenges. Timely identification of “red flags” in diagnosis, therapeutic reassessment, and myasthenic crisis is crucial to optimizing patient outcomes. This Delphi‐based consensus is aimed at
Francesco Habetswallner, Luca Bello, Fiammetta Biasini, Bernardo Maria De Martino, Fiammetta Vanoli, Paolo E. Alboini, Giovanni Antonini, Carlo Antozzi, Valentina Damato, Vincenzo Di Stefano, Amelia Evoli, Matteo Gastaldi, Raffaele Iorio, Michelangelo Maestri, Renato Mantegazza, Roberto Massa, Rita Rinaldi, Francesco Saccà, Carmelo Rodolico, Dominic B. Fee   +19 more
wiley   +1 more source

PDK4 and nutrient responses explain muscle specific manifestation in mitochondrial disease

Clinical and Translational Medicine, Volume 15, Issue 7, July 2025.
Mitochondrial disease triggers opposite responses in different muscles. Mitochondrial integrated stress response (ISRmt) and aerobic glycolysis characterize large muscles. Eye muscles show no ISRmt but activate PDK4—inhibitor of glucose oxidation—thereby upregulating beta‐oxidation, which is non‐optimal in mitochondrial disease and can explain eye ...
Swagat Pradhan, Takayuki Mito, Nahid A Khan, Sofiia Olander, Aleksandra Zhaivoron, Thomas G McWilliams, Anu Suomalainen   +6 more
wiley   +1 more source

Unrecognized side effect of statin treatment: unilateral blepharoptosis

, 2006
A 43-year-old man receiving statin monotherapy (10 mg atorvastatin) for hypercholesterolemia had unilateral blepharoptosis as the result of isolated myositis of the levator muscle. Statin-induced myositis in the levator muscle should be considered in the
Ertas, Nilgun Markal, Atmaca, Yusuf, Erol, Cetin, Sener, Cumhur, Tanju, Sumru, Ertas, Fatih Sinan, Gulec, Sadi   +6 more
core   +1 more source

OXA1L deficiency causes mitochondrial myopathy via reactive oxygen species regulated nuclear factor kappa B signalling pathway

Clinical and Translational Medicine, Volume 15, Issue 6, June 2025.
OXA1L gene bi‐allelic variants cause mitochondrial myopathy. OXA1L deficiency results in combined mitochondrial respiratory chain defects and OXPHOS impairments. OXA1L deficiency leads to elevated ROS production, which may activate the NF‐κB signalling pathway, disturbing myogenic gene expression and triggering cell apoptosis. Abstract Background OXA1L
Yongkun Zhan, Qian Wang, Ya Wang, Yanjie Fan, Dan Yan, Xianlong Lin, Yaoting Chen, Tingting Hu, Nan Li, Weiqian Dai, Hezhi Fang, Yongguo Yu   +11 more
wiley   +1 more source

Observation of Safety and Efficacy of Botulinum Toxin Type A in the Treatment of Tear Troughs and Mild Yelid Bags

Journal of Cosmetic Dermatology, Volume 24, Issue 6, June 2025.
ABSTRACT Objective To evaluate the safety and efficacy of Botulinum Toxin Type A (BTX‐A) injection for the treatment of tear troughs. Method This study included patients with tear troughs rated as Grade 1–2 on the Barton Aesthetic Scale, who were treated between September 2023 and September 2024.
Siyuan Zhou, Homgtao Liu, Zhongjie Pan, Fuqiang Pan, Qian Liang, Houhuang Qiu, Bingliang Wu, Liming Zhang, Xiang Zhou   +8 more
wiley   +1 more source

Blepharoptosis and cysticercosis

Nepalese Journal of Ophthalmology, 2013
Nepal J Ophthalmol 2013; 5(10): 286 DOI: http://dx.doi.org/10.3126/nepjoph.v5i2 ...
openaire   +3 more sources

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14‐Year Experience of an Academic Center

Hematological Oncology, Volume 43, Issue 3, May 2025.
ABSTRACT Localized light chain amyloidosis (loc‐AL) is a rare disorder characterized by localized deposition of misfolded AL fibrils. There are limited data on patterns of disease presentation and long‐term outcomes. In this study, we retrospectively reviewed 146 patients with loc‐AL at our institution between January 1, 2010, and March 1, 2024.
Danai Dima, Utkarsh Goel, Fauzia Ullah, Beth Faiman, Diana Basali, Sandra Mazzoni, Louis S. Williams, Christy Samaras, Jason Valent, Faiz Anwer, Jack Khouri, Shahzad Raza   +11 more
wiley   +1 more source

Transient and isolated neurogenic blepharoptosis after medial orbital wall reconstruction.

, 2014
Neurogenic blepharoptosis related to orbital surgery is very rare and only 1 report was published in the literature. This report presents 1 case of transient and isolated neurogenic blepharoptosis after medial orbital wall reconstruction.
Lim, SY, Song, H, Lee, IJ, Park, DH, Park, MC   +4 more
core   +1 more source